Find clinical trials for Non-Hodgkin Lymphoma in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Warszawa, Mazowieckie, POL:
The goal of the study is to assess the safety and anti-lymphoma activity of MEN1703 (Dapolsertib hydrochloride) when given as a single-agent-...
Phase 2
Warsaw, Poland and 22 other locations
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed orig...
Phase 4
Warszawa, Poland and 34 other locations
This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK...
Phase 1, Phase 2
Warszawa, Poland and 37 other locations
This study is researching an investigational drug, odronextamab, in adult patients B-cell non-Hodgkin's lymphoma (B-NHL).T...
Phase 2
Warszawa, Mazowieckie, Poland and 140 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Warszawa, Poland and 55 other locations
The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefi...
Phase 3
Warszawa, Mazowieckie, Poland and 55 other locations
The primary purpose of the study is to assess safety, and to identify the recommended phase 2 dose (RP2D) of tolinapant in combination with oral deci...
Phase 1, Phase 2
Warsaw, Masovia, Poland and 45 other locations
in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma....
Phase 3
Warszawa, Poland and 227 other locations
The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...
Phase 1, Phase 2
Warszawa, Poland and 84 other locations
This study will provide continuing availability to tazemetostat for people that have previously completed participation in a tazemetostat study, eith...
Phase 1, Phase 2
Warszawa, Poland and 33 other locations
Clinical trials
Research sites
Resources
Legal